PF-Atlas › Clinical Trials › NCT04855305
Optimizing and Standardizing 129Xe Gas Exchange MRI to Visualize Regional Therapy Response in Interstitial Lung Disease
Hyperpolarized 129Xe · Phase 2
Registry ID
NCT04855305
Phase
Phase 2
Status
Completed
Drug / intervention
Hyperpolarized 129Xe
Sponsor
Bastiaan Driehuys
Start
2021-11-12
About this trial
Hyperpolarized 129Xe is evaluated in NCT04855305, a Phase 2 idiopathic pulmonary fibrosis study sponsored by Bastiaan Driehuys. Current status: Completed.
Explore related
Medical disclaimer. This page summarizes public trial data for NCT04855305 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.